While TET2 mutations have been associated with blast transformation in myeloproliferative neoplasms and unfavorable prognosis in acute myeloid leukemia [23,24,25], other studies failed to identify a strong association between TET2 mutations and overall survival [20,26]. Here, TET2 is linked to myeloproliferative disorder.